药品研发聚焦的十大疾病领域：癌症排名**

2017-07-21 佚名生物探索

据Analysis Group统计，截止到2016年8月，研究项目数量排名前十的依次为，癌症（Cancer）8651项，神经学(Neurology)2517项，传染病(Infections)2167项，免疫(Immunology)1601项，心血管疾病(Cardiovascular)1097项，肌肉骨骼(Musculoskeletal)963项，呼吸系统(Respiratory)930项，皮肤(S

据Analysis Group统计，截止到2016年8月，研究项目数量排名前十的依次为，癌症（Cancer）8651项，神经学(Neurology)2517项，传染病(Infections)2167项，免疫(Immunology)1601项，心血管疾病(Cardiovascular)1097项，肌肉骨骼(Musculoskeletal)963项，呼吸系统(Respiratory)930项，皮肤(Skin)822项，感觉器(Sensory organs)768项，糖尿病(Diabetes)749项。

图片来源：Endpoints News

对于那些关注药物研发趋势的人来说，癌症在新药研发项目数量中占据第一，这一点不会让人感到意外。但令人惊讶的是，肿瘤对这个行业的主导程度是前所未有的。

FDA全票推荐诺华Car-T上市，以”PD-1/PD-L1”为代表的免疫药物在癌症研究和治疗领域大放异彩。据Analysis Group提供的数据，癌症占了总pipeline项目中的8，651个，这个数字比EvaluatePharma跟踪的临床前到临床III期的24，389个项目的三分之一还要多。

同时也比排在癌症之后的5个疾病领域的综合项目还要多。排名第二的神经学领域，该领域的帕金森和阿尔茨海默症，曾经一度是制药研发的重点领域，共有468个项目，还没有进入前10。

往下游看，癌症研究占据了主导地位。3723个临床I期项目，癌症占据了近乎一半，1757个。临床II期4424个项目，1920个是癌症项目。只有在临床III期的项目中，癌症才开始失去其压倒性的优势，占1257个项目中的329个。

图片来源：Endpoints News

PhRMA撰写这份报告强调了行业在研发和重大新药开发上的投入程度。同时，该报告还提出了以下几点：

（1）四分之三的处于临床研究的项目，都在争取first-in-class地位，突显行业对可以为患者带来改变的新药的重视。Me-too的药物已经完全过时，不太可能会被买账。

（2）在所有临床阶段的项目中，822个是孤儿药，服务于20万人以下的市场。但国外孤儿药市场是一片蓝海，《孤儿药法案》等激励和促进孤儿药的研发和商业化。

（3）总共有731个细胞治疗和基因治疗项目处于临床阶段。美国FDA全票推荐诺华CAR-T疗法批准上市，是为全球首次。随着诺华（Novartis）和凯特（Kite）相继提交生物制品上市申请，美国FDA批准的首款CAR-T免疫细胞商业化疗法大概率会在2017年上市。本周，Spark Therapeutics的新药LUXTURNA也获得优先审评资格。

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言

评论区 (8)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=2045684, encodeId=2895204568467, content=<a href='/topic/show?id=f9ec8e465b4' target=_blank style='color:#2F92EE;'>#药品研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87465, encryptionId=f9ec8e465b4, topicName=药品研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e729101, createdName=huanbaofeng, createdTime=Fri Nov 10 19:33:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992433, encodeId=72b41992433e6, content=<a href='/topic/show?id=b98435e1424' target=_blank style='color:#2F92EE;'>#十大疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35714, encryptionId=b98435e1424, topicName=十大疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Fri Jan 26 06:33:00 CST 2018, time=2018-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225332, encodeId=6b2422533230, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicUw7yoAI4gptl6B3VGw6WZJ0uC02gdsRKGWuUVO3YSn6iagP9laH8FZIo3kTr5Xb9ricn6kqveJVs6FOWPec9yClJFkTXHtxSA/0, createdBy=a44f1685526, createdName=drdentist, createdTime=Sun Jul 23 08:41:36 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300038, encodeId=32291300038c7, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sun Jul 23 07:33:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225169, encodeId=8a732251690f, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220603/c17fc0ab722247a2b189f090e29e8ee6/af7335888a4b49eda7182250260680dd.jpg, createdBy=6ea72090959, createdName=爱生活更爱你, createdTime=Sat Jul 22 22:10:46 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224789, encodeId=ab5c224e8931, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Fri Jul 21 23:36:17 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224722, encodeId=0226224e22a6, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Jul 21 19:04:39 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224705, encodeId=358b224e05d8, content=很好，学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/17/3872cad7a53dc9dcbd08202fb6313cf4.jpg, createdBy=2cb71609450, createdName=KO229256262, createdTime=Fri Jul 21 18:09:43 CST 2017, time=2017-07-21, status=1, ipAttribution=)]
2017-11-10 huanbaofeng

#药品研发#

0 0
[GetPortalCommentsPageByObjectIdResponse(id=2045684, encodeId=2895204568467, content=<a href='/topic/show?id=f9ec8e465b4' target=_blank style='color:#2F92EE;'>#药品研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87465, encryptionId=f9ec8e465b4, topicName=药品研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e729101, createdName=huanbaofeng, createdTime=Fri Nov 10 19:33:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992433, encodeId=72b41992433e6, content=<a href='/topic/show?id=b98435e1424' target=_blank style='color:#2F92EE;'>#十大疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35714, encryptionId=b98435e1424, topicName=十大疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Fri Jan 26 06:33:00 CST 2018, time=2018-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225332, encodeId=6b2422533230, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicUw7yoAI4gptl6B3VGw6WZJ0uC02gdsRKGWuUVO3YSn6iagP9laH8FZIo3kTr5Xb9ricn6kqveJVs6FOWPec9yClJFkTXHtxSA/0, createdBy=a44f1685526, createdName=drdentist, createdTime=Sun Jul 23 08:41:36 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300038, encodeId=32291300038c7, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sun Jul 23 07:33:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225169, encodeId=8a732251690f, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220603/c17fc0ab722247a2b189f090e29e8ee6/af7335888a4b49eda7182250260680dd.jpg, createdBy=6ea72090959, createdName=爱生活更爱你, createdTime=Sat Jul 22 22:10:46 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224789, encodeId=ab5c224e8931, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Fri Jul 21 23:36:17 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224722, encodeId=0226224e22a6, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Jul 21 19:04:39 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224705, encodeId=358b224e05d8, content=很好，学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/17/3872cad7a53dc9dcbd08202fb6313cf4.jpg, createdBy=2cb71609450, createdName=KO229256262, createdTime=Fri Jul 21 18:09:43 CST 2017, time=2017-07-21, status=1, ipAttribution=)]
2018-01-26 yanjie6253_56072842

#十大疾病#

34 0
[GetPortalCommentsPageByObjectIdResponse(id=2045684, encodeId=2895204568467, content=<a href='/topic/show?id=f9ec8e465b4' target=_blank style='color:#2F92EE;'>#药品研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87465, encryptionId=f9ec8e465b4, topicName=药品研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e729101, createdName=huanbaofeng, createdTime=Fri Nov 10 19:33:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992433, encodeId=72b41992433e6, content=<a href='/topic/show?id=b98435e1424' target=_blank style='color:#2F92EE;'>#十大疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35714, encryptionId=b98435e1424, topicName=十大疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Fri Jan 26 06:33:00 CST 2018, time=2018-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225332, encodeId=6b2422533230, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicUw7yoAI4gptl6B3VGw6WZJ0uC02gdsRKGWuUVO3YSn6iagP9laH8FZIo3kTr5Xb9ricn6kqveJVs6FOWPec9yClJFkTXHtxSA/0, createdBy=a44f1685526, createdName=drdentist, createdTime=Sun Jul 23 08:41:36 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300038, encodeId=32291300038c7, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sun Jul 23 07:33:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225169, encodeId=8a732251690f, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220603/c17fc0ab722247a2b189f090e29e8ee6/af7335888a4b49eda7182250260680dd.jpg, createdBy=6ea72090959, createdName=爱生活更爱你, createdTime=Sat Jul 22 22:10:46 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224789, encodeId=ab5c224e8931, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Fri Jul 21 23:36:17 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224722, encodeId=0226224e22a6, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Jul 21 19:04:39 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224705, encodeId=358b224e05d8, content=很好，学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/17/3872cad7a53dc9dcbd08202fb6313cf4.jpg, createdBy=2cb71609450, createdName=KO229256262, createdTime=Fri Jul 21 18:09:43 CST 2017, time=2017-07-21, status=1, ipAttribution=)]
2017-07-23 drdentist

很好

71 0
[GetPortalCommentsPageByObjectIdResponse(id=2045684, encodeId=2895204568467, content=<a href='/topic/show?id=f9ec8e465b4' target=_blank style='color:#2F92EE;'>#药品研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87465, encryptionId=f9ec8e465b4, topicName=药品研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e729101, createdName=huanbaofeng, createdTime=Fri Nov 10 19:33:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992433, encodeId=72b41992433e6, content=<a href='/topic/show?id=b98435e1424' target=_blank style='color:#2F92EE;'>#十大疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35714, encryptionId=b98435e1424, topicName=十大疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Fri Jan 26 06:33:00 CST 2018, time=2018-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225332, encodeId=6b2422533230, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicUw7yoAI4gptl6B3VGw6WZJ0uC02gdsRKGWuUVO3YSn6iagP9laH8FZIo3kTr5Xb9ricn6kqveJVs6FOWPec9yClJFkTXHtxSA/0, createdBy=a44f1685526, createdName=drdentist, createdTime=Sun Jul 23 08:41:36 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300038, encodeId=32291300038c7, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sun Jul 23 07:33:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225169, encodeId=8a732251690f, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220603/c17fc0ab722247a2b189f090e29e8ee6/af7335888a4b49eda7182250260680dd.jpg, createdBy=6ea72090959, createdName=爱生活更爱你, createdTime=Sat Jul 22 22:10:46 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224789, encodeId=ab5c224e8931, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Fri Jul 21 23:36:17 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224722, encodeId=0226224e22a6, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Jul 21 19:04:39 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224705, encodeId=358b224e05d8, content=很好，学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/17/3872cad7a53dc9dcbd08202fb6313cf4.jpg, createdBy=2cb71609450, createdName=KO229256262, createdTime=Fri Jul 21 18:09:43 CST 2017, time=2017-07-21, status=1, ipAttribution=)]
2017-07-23 lqvr

#研发#

50 0
[GetPortalCommentsPageByObjectIdResponse(id=2045684, encodeId=2895204568467, content=<a href='/topic/show?id=f9ec8e465b4' target=_blank style='color:#2F92EE;'>#药品研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87465, encryptionId=f9ec8e465b4, topicName=药品研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e729101, createdName=huanbaofeng, createdTime=Fri Nov 10 19:33:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992433, encodeId=72b41992433e6, content=<a href='/topic/show?id=b98435e1424' target=_blank style='color:#2F92EE;'>#十大疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35714, encryptionId=b98435e1424, topicName=十大疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Fri Jan 26 06:33:00 CST 2018, time=2018-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225332, encodeId=6b2422533230, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicUw7yoAI4gptl6B3VGw6WZJ0uC02gdsRKGWuUVO3YSn6iagP9laH8FZIo3kTr5Xb9ricn6kqveJVs6FOWPec9yClJFkTXHtxSA/0, createdBy=a44f1685526, createdName=drdentist, createdTime=Sun Jul 23 08:41:36 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300038, encodeId=32291300038c7, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sun Jul 23 07:33:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225169, encodeId=8a732251690f, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220603/c17fc0ab722247a2b189f090e29e8ee6/af7335888a4b49eda7182250260680dd.jpg, createdBy=6ea72090959, createdName=爱生活更爱你, createdTime=Sat Jul 22 22:10:46 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224789, encodeId=ab5c224e8931, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Fri Jul 21 23:36:17 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224722, encodeId=0226224e22a6, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Jul 21 19:04:39 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224705, encodeId=358b224e05d8, content=很好，学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/17/3872cad7a53dc9dcbd08202fb6313cf4.jpg, createdBy=2cb71609450, createdName=KO229256262, createdTime=Fri Jul 21 18:09:43 CST 2017, time=2017-07-21, status=1, ipAttribution=)]
2017-07-22 爱生活更爱你

不错

74 0
[GetPortalCommentsPageByObjectIdResponse(id=2045684, encodeId=2895204568467, content=<a href='/topic/show?id=f9ec8e465b4' target=_blank style='color:#2F92EE;'>#药品研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87465, encryptionId=f9ec8e465b4, topicName=药品研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e729101, createdName=huanbaofeng, createdTime=Fri Nov 10 19:33:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992433, encodeId=72b41992433e6, content=<a href='/topic/show?id=b98435e1424' target=_blank style='color:#2F92EE;'>#十大疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35714, encryptionId=b98435e1424, topicName=十大疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Fri Jan 26 06:33:00 CST 2018, time=2018-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225332, encodeId=6b2422533230, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicUw7yoAI4gptl6B3VGw6WZJ0uC02gdsRKGWuUVO3YSn6iagP9laH8FZIo3kTr5Xb9ricn6kqveJVs6FOWPec9yClJFkTXHtxSA/0, createdBy=a44f1685526, createdName=drdentist, createdTime=Sun Jul 23 08:41:36 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300038, encodeId=32291300038c7, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sun Jul 23 07:33:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225169, encodeId=8a732251690f, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220603/c17fc0ab722247a2b189f090e29e8ee6/af7335888a4b49eda7182250260680dd.jpg, createdBy=6ea72090959, createdName=爱生活更爱你, createdTime=Sat Jul 22 22:10:46 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224789, encodeId=ab5c224e8931, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Fri Jul 21 23:36:17 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224722, encodeId=0226224e22a6, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Jul 21 19:04:39 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224705, encodeId=358b224e05d8, content=很好，学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/17/3872cad7a53dc9dcbd08202fb6313cf4.jpg, createdBy=2cb71609450, createdName=KO229256262, createdTime=Fri Jul 21 18:09:43 CST 2017, time=2017-07-21, status=1, ipAttribution=)]
2017-07-21 luominglian113

学习了，谢谢分享

59 0
[GetPortalCommentsPageByObjectIdResponse(id=2045684, encodeId=2895204568467, content=<a href='/topic/show?id=f9ec8e465b4' target=_blank style='color:#2F92EE;'>#药品研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87465, encryptionId=f9ec8e465b4, topicName=药品研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e729101, createdName=huanbaofeng, createdTime=Fri Nov 10 19:33:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992433, encodeId=72b41992433e6, content=<a href='/topic/show?id=b98435e1424' target=_blank style='color:#2F92EE;'>#十大疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35714, encryptionId=b98435e1424, topicName=十大疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Fri Jan 26 06:33:00 CST 2018, time=2018-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225332, encodeId=6b2422533230, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicUw7yoAI4gptl6B3VGw6WZJ0uC02gdsRKGWuUVO3YSn6iagP9laH8FZIo3kTr5Xb9ricn6kqveJVs6FOWPec9yClJFkTXHtxSA/0, createdBy=a44f1685526, createdName=drdentist, createdTime=Sun Jul 23 08:41:36 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300038, encodeId=32291300038c7, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sun Jul 23 07:33:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225169, encodeId=8a732251690f, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220603/c17fc0ab722247a2b189f090e29e8ee6/af7335888a4b49eda7182250260680dd.jpg, createdBy=6ea72090959, createdName=爱生活更爱你, createdTime=Sat Jul 22 22:10:46 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224789, encodeId=ab5c224e8931, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Fri Jul 21 23:36:17 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224722, encodeId=0226224e22a6, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Jul 21 19:04:39 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224705, encodeId=358b224e05d8, content=很好，学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/17/3872cad7a53dc9dcbd08202fb6313cf4.jpg, createdBy=2cb71609450, createdName=KO229256262, createdTime=Fri Jul 21 18:09:43 CST 2017, time=2017-07-21, status=1, ipAttribution=)]
2017-07-21 虈亣靌

学习了谢谢分享

59 0
[GetPortalCommentsPageByObjectIdResponse(id=2045684, encodeId=2895204568467, content=<a href='/topic/show?id=f9ec8e465b4' target=_blank style='color:#2F92EE;'>#药品研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87465, encryptionId=f9ec8e465b4, topicName=药品研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e729101, createdName=huanbaofeng, createdTime=Fri Nov 10 19:33:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992433, encodeId=72b41992433e6, content=<a href='/topic/show?id=b98435e1424' target=_blank style='color:#2F92EE;'>#十大疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35714, encryptionId=b98435e1424, topicName=十大疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Fri Jan 26 06:33:00 CST 2018, time=2018-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225332, encodeId=6b2422533230, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicUw7yoAI4gptl6B3VGw6WZJ0uC02gdsRKGWuUVO3YSn6iagP9laH8FZIo3kTr5Xb9ricn6kqveJVs6FOWPec9yClJFkTXHtxSA/0, createdBy=a44f1685526, createdName=drdentist, createdTime=Sun Jul 23 08:41:36 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300038, encodeId=32291300038c7, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sun Jul 23 07:33:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225169, encodeId=8a732251690f, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220603/c17fc0ab722247a2b189f090e29e8ee6/af7335888a4b49eda7182250260680dd.jpg, createdBy=6ea72090959, createdName=爱生活更爱你, createdTime=Sat Jul 22 22:10:46 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224789, encodeId=ab5c224e8931, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Fri Jul 21 23:36:17 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224722, encodeId=0226224e22a6, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Jul 21 19:04:39 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224705, encodeId=358b224e05d8, content=很好，学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/17/3872cad7a53dc9dcbd08202fb6313cf4.jpg, createdBy=2cb71609450, createdName=KO229256262, createdTime=Fri Jul 21 18:09:43 CST 2017, time=2017-07-21, status=1, ipAttribution=)]
2017-07-21 KO229256262

很好，学习了，谢谢分享

62 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肿瘤科

药品研发聚焦的十大疾病领域：癌症排名**

相关资讯

科室

工具

服务